ProShare Advisors LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q2 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$48,102
-38.5%
15,319
+1.0%
0.00%
Q2 2023$78,257
+3.1%
15,166
+5.3%
0.00%
Q1 2023$75,930
+65.9%
14,408
-11.5%
0.00%
Q4 2022$45,758
-26.2%
16,284
+8.7%
0.00%
Q3 2022$62,000
+5.1%
14,986
+2.4%
0.00%
Q2 2022$59,000
-46.8%
14,633
-34.4%
0.00%
Q1 2022$111,000
-42.2%
22,316
-18.9%
0.00%
Q4 2021$192,000
-26.7%
27,532
+5.1%
0.00%
-100.0%
Q3 2021$262,000
-45.0%
26,185
-22.1%
0.00%0.0%
Q2 2021$476,000
-2.9%
33,594
+12.4%
0.00%
-50.0%
Q1 2021$490,000
-9.8%
29,885
+14.0%
0.00%0.0%
Q4 2020$543,000
+924.5%
26,216
+49.8%
0.00%
Q3 2019$53,000
-26.4%
17,500
+7.5%
0.00%
Q2 2019$72,000
+1.4%
16,280
-9.0%
0.00%
Q1 2019$71,000
+2.9%
17,889
+2.5%
0.00%
Q4 2018$69,000
-42.5%
17,445
+0.1%
0.00%
-100.0%
Q3 2016$120,000
+17.6%
17,423
-15.5%
0.00%
+100.0%
Q2 2016$102,000
-47.2%
20,623
+3.1%
0.00%
-66.7%
Q1 2016$193,000
-6.8%
20,009
-9.4%
0.00%0.0%
Q4 2015$207,00022,0780.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2016
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders